Category: Pharma Industry

Louisiana AG Defends State 340B Contract Pharmacy Law Against Drug Industry Lawsuit

September 14, 2023 William Newton, Associate Editor/Senior Writer Views

Four hospital associations filed an amicus brief in support of Louisiana Attorney General Jeff Landry's defense of his state's contract pharmacy law.

The Louisiana attorney general recently asked a federal district judge to dismiss a drug industry lawsuit that challenges Louisiana’s 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two More Drugmakers Owe 340B Provider Repayments, HRSA Audits Find

September 14, 2023 Rich Daly, Editor in Chief Views

The Health Resources and Services Administration announced that the Office of Pharmacy Affairs will hold a June 11 webinar on the ADR final rule.

Two drugmakers owe repayment to 340B covered entities, according to final audits posted this week by federal officials. American Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Jazz Pharmaceuticals Is 25th Drugmaker to Implement Contract Pharmacy Restrictions

September 12, 2023 Rich Daly, Editor in Chief Views

Jazz Pharmaceuticals owes refunds to 340B providers, according to a notice posted on HRSA's website.

Drug manufacturer Jazz Pharmaceuticals this week became the 25th drug manufacturer to impose conditions on 340B pricing involving delivery to contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sanofi Withdraws Some Health Centers’ 340B Pricing at Contract Pharmacies

September 12, 2023 Tom Mirga, Editor at Large Views

Sanofi has recently denied some health centers access to 340B pricing at contract pharmacies after saying they did not conform to Sanofi's policy.

Drug manufacturer Sanofi recently started denying access for some health centers to 340B pricing at contract pharmacies after previously saying [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck Offering Refunds to 340B Covered Entities

September 12, 2023 Tom Mirga, Editor at Large Views

Merck is the first drug manufacturer to announce it is issuing refunds to 340B providers in 2024.

Drug manufacturer Merck recently announced that it owes refunds to 340B covered entities for purchases of 17 products during the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sources Cited in Drugmakers’ Brief Question Accuracy in High-Profile 340B Patient Definition Case

September 8, 2023 Tom Mirga, Editor at Large Views

Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.

Inaccurate points were ascribed to 340B advisers and service providers in a recent legal filing by four drugmakers as part [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Janssen Issuing Refunds for 340B Overcharges

September 8, 2023 Tom Mirga, Editor at Large Views

Janssen Biotech is paying refunds for overcharges on certain 340B drugs purchased in the third quarter of 2020.

Drug manufacturer Janssen Biotech recently determined that it owes or may owe refunds to some 340B covered entities. The refunds [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

PhRMA to Federal Appeals Court: Arkansas Enforcing 340B Contract Pharmacy Law; Seventh Drugmaker Sues Over IRA

September 6, 2023 William Newton, Associate Editor/Senior Writer Views

PhRMA filed a citation to notify the U.S. Eighth Circuit Court of Appeals in St. Louis that Arkansas is enforcing its 340B contract pharmacy law.

The drug industry group challenging the legality of Arkansas’ 340B contract pharmacy law, notified a federal appeals court that the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Tolmar Providing Refunds for Five Years of 340B Overcharges

September 6, 2023 Tom Mirga, Editor at Large Views

Drugmaker Tolmar said it will refund 340B covered entities for overcharges on certain generic dermatologic products.

Drug manufacturer Tolmar recently said it plans refunds to 340B covered entities for overcharges on seven generic dermatologic products purchased [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

UCB Tightens 340B Contract Pharmacy Restrictions for Hospitals

September 5, 2023 William Newton, Associate Editor/Senior Writer Views

UCB announced it will tighten its existing 340B contract restrictions on hospitals beginning Oct. 2.

Belgium drug maker UCB will add restrictions on 340B contract pharmacy use for hospitals starting Oct. 2, according to a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live